0001666071-21-000048.txt : 20210405
0001666071-21-000048.hdr.sgml : 20210405
20210405201535
ACCESSION NUMBER: 0001666071-21-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grimes Scott D.
CENTRAL INDEX KEY: 0001617486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 21807689
MAIL ADDRESS:
STREET 1: C/O EVERGY, INC.
STREET 2: 1200 MAIN STREET
CITY: KANSAS CITY
STATE: MO
ZIP: 64105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_161766804612602.xml
FORM 4
X0306
4
2021-04-01
0
0001666071
Cardlytics, Inc.
CDLX
0001617486
Grimes Scott D.
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
0
0
0
Common Stock
2021-04-01
4
M
0
14919
0
A
251827
D
Common Stock
2021-04-05
4
S
0
335
111.23
D
88777
I
See Footnote
Common Stock
2021-04-05
4
S
0
800
112.48
D
87977
I
See Footnote
Common Stock
2021-04-05
4
S
0
165
113.31
D
87812
I
See Footnote
Common Stock
2021-04-05
4
S
0
200
114.68
D
87612
I
See Footnote
Common Stock
2021-04-05
4
S
0
300
116.85
D
87312
I
See Footnote
Common Stock
2021-04-05
4
S
0
200
118.43
D
87112
I
See Footnote
Restricted Stock Unit
2021-04-01
4
M
0
14919
0
D
Common Stock
14919.0
44759
D
Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (6), (7), (8), and (9) to this Form 4.
The reportable securities are held by the GRAT.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $112.06 to $112.82, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $113.08 to $113.37, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $114.63 to $114.72, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $116.43 to $117.41, inclusive.
The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.
/s/ Kirk Somers, Attorney-in-Fact
2021-04-05